MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease

Bone fragility is highly prevalent, yet underdiagnosed in patients with chronic kidney disease. Incomplete understanding of the pathophysiology and limitations of current diagnostics contribute to therapeutic hesitation, if not nihilism. This narrative review addresses the question of whether microR...

Descripción completa

Detalles Bibliográficos
Autores principales: Smout, Dieter, Van Craenenbroeck, Amaryllis H, Jørgensen, Hanne Skou, Evenepoel, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972833/
https://www.ncbi.nlm.nih.gov/pubmed/36865016
http://dx.doi.org/10.1093/ckj/sfac219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972833/
https://www.ncbi.nlm.nih.gov/pubmed/36865016
http://dx.doi.org/10.1093/ckj/sfac219

Ejemplares similares